Hapvida Participacoes e Investimentos SA HAPV3
BMFBOVESPA · Brazil · Health Services
BRL 7.17+0.20 (+2.87%)
Market open· · BRL · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · BRL · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Hapvida Participacoes Investimento SA (BSP:HAPV3) navigates a pivotal quarter with a 12-month plan to reprice contracts, cut costs, and reduce litigation pressure despite a slight membership dip.
The recent reset in the fair value estimate for Hapvida Participações e Investimentos from R$26.09 to R$13.96 sits alongside price targets such as R$19 that frame a more conservative central case for the stock. Some analysts link this recalibration to mixed views on execution, where optimism about contract repricing and EBITDA margin recovery competes with concerns after a difficult 2025. As you read on, you will see how these shifting targets fit into the wider narrative and what to watch to...
Hapvida Participacoes Investimento SA (BSP:HAPV3) outlines its strategic initiatives and financial strategies to navigate market complexities and enhance operational efficiency.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.